Takayuki Kii
Takatsuki, 5698686, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Measurement of x-ray bremsstrahlung radiation from high energy electrons by stochastic acceleration in Heliotron J.
Journal: The Review of scientific instruments
Published: July 31, 2024
A phase II study of S-1 therapy for patients with advanced and recurrent esophageal cancer resistant or intolerable to fluorouracil, platinum, and taxane therapy (OGSG 1404).
Journal: Esophagus : official journal of the Japan Esophageal Society
Published: February 14, 2022
Sequential Treatment Strategy Using Fluoropyrimidine plus Bevacizumab Followed by Oxaliplatin for Metastatic Colorectal Cancer: A Phase II Study (OGSG 1107).
Journal: Gastrointestinal tumors
Published: August 12, 2021
Randomized phase II study of docetaxel versus paclitaxel in patients with esophageal squamous cell carcinoma refractory to fluoropyrimidine- and platinum-based chemotherapy: OGSG1201.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 08, 2021
Retrospective Comparison of mFOLFOXIRI With XELOX/SOX as Neoadjuvant Chemotherapy for Locally Advanced Rectal Cancer.
Journal: In vivo (Athens, Greece)
Published: October 29, 2020
A Case of Remnant Gastric Cancer Occurring 12 Years after Surgery That Was Successfully Treated with Radiation Therapy
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: June 17, 2020
Long-term results of a randomized controlled trial comparing neoadjuvant Adriamycin, cisplatin, and 5-fluorouracil vs docetaxel, cisplatin, and 5-fluorouracil followed by surgery for esophageal cancer (OGSG1003).
Journal: Annals of gastroenterological surgery
Published: June 07, 2020
Phase Ib/II Study of Biweekly TAS-102 in Combination with Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies (BiTS Study).
Journal: The oncologist
Published: April 29, 2020
Endoscopic Evaluation of Neoadjuvant Chemotherapeutic Efficacy in Gastric Cancer before Gastrectomy Might be as Useful as Histological Assessment after Gastrectomy.
Journal: Digestion
Published: March 16, 2019
A 3-Year Overall Survival Update From a Phase 2 Study of Chemoselection With DCF and Subsequent Conversion Surgery for Locally Advanced Unresectable Esophageal Cancer.
Journal: Annals of surgical oncology
Published: March 13, 2019
Fluoropyrimidine-induced intestinal mucosal injury is associated with the severity of chemotherapy-related diarrhea.
Journal: Scandinavian journal of gastroenterology
Published: February 12, 2019
Impact of modified FOLFOX-6 for patients with gastric cancer and a gastrointestinal obstruction.
Journal: Asia-Pacific journal of clinical oncology
Published: January 14, 2018
Last Updated: 09/26/2026